RxDoctor Payments Data

Sara Douglas, NP

Nurse Practitioner · Cedar Falls, IANPI 1639154016

Payments from drug & device makers

$313in general payments, 2019–2025

Across 12 payments — averaging $26.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$83
  • Pfizer$43
  • Novo Nordisk$42
  • Abbott$40
  • Lilly USA, LLC$30
  • Astellas Pharma US Inc$26
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$313100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$313 in reported general payments places this provider in the 70th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Medicare billing

Part B allowed, 2024
$35,015
Medicare patients
169
Services billed
612

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$30,043
MounjaroTirzepatide27$28,421
EliquisApixaban27$15,754
Repatha SyringeEvolocumab14$7,743
MyrbetriqMirabegron14$7,512
Breo ElliptaFluticasone/Vilanterol17$6,705
NamzaricMemantine Hcl/Donepezil Hcl11$6,322
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$4,375
SymbicortBudesonide/Formoterol Fumarate17$4,025
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,307
BrilintaTicagrelor13$3,117
Levothyroxine Sodium284$2,698
Atorvastatin Calcium260$2,473
Albuterol Sulfate HfaAlbuterol Sulfate77$1,876
Gabapentin145$1,827

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$42$30,04328 claims
Lilly USA, LLCMounjaro$30$28,42127 claims
PfizerEliquis, Dilantin$43$17,52539 claims
GSKBreo Ellipta, Shingrix$15$10,01332 claims
Astellas Pharma US IncMyrbetriq$26$7,51214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,346 nurse practitioner providers in Iowa.

Other nurse practitioner in Cedar Falls

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →